Summary of findings for multi‐dose nasal decongestant vs placebo
Secondary outcome: all adverse eventsTopical · adult patients with the common cold
1 finding from 1 review
- no estimate extracted1 study · 61 participantsGRADE not reported
Findings
What do systematic reviews say?
5 questions · 7 findings · 1 reviews
No studies found 0 · 0%GRADE not reported 4 · 57.1%Very low 0 · 0%Low 3 · 42.9%Moderate 0 · 0%High 0 · 0%
Summary of findings for multi‐dose nasal decongestant vs placebo
Primary outcome: subjective symptom score (mean) ‐ 3 hours after dosing · adult patients with the common cold
3 findings from 1 review
- no estimate extracted2 studies · 94 participantsLow
- no estimate extracted1 study · 33 participantsGRADE not reported
- no estimate extracted1 study · 61 participantsGRADE not reported
Summary of findings for multi‐dose nasal decongestant vs placebo
Outcomes relevant to participants' well‐being · adult patients with the common cold
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Summary of findings for multi‐dose nasal decongestant vs placebo
Secondary outcome: all adverse events · adult patients with the common cold
Summary of findings for multi‐dose nasal decongestant showed no clear difference in secondary outcome: all adverse events compared with placebo (low certainty).
1 finding from 1 review
- OR 0.98 [0.68, 1.4]7 studies · 1195 participantsLow
Summary of findings for multi‐dose nasal decongestant vs placebo
Secondary outcome: all adverse eventsOral · adult patients with the common cold
Summary of findings for multi‐dose nasal decongestant showed no clear difference in secondary outcome: all adverse eventsOral compared with placebo (low certainty).
1 finding from 1 review
- OR 0.95 [0.65, 1.39]6 studies · 1134 participantsLow